E2 Raises $80M to Market Thrombectomy Platform
Disco Pharmaceuticals Secures €36M Seed Funding
E2 Raises $80M in Series C Funding to Advance Pulmonary Embolism Treatment
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap